Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults.

BACKGROUND Patients hospitalized with influenza may require extended care on discharge. We aimed to explore predictors for extended care needs and the potential mitigating effect of antiviral treatment among community-dwelling adults aged ≥ 65 years hospitalized with influenza. METHODS We used laboratory-confirmed influenza hospitalizations from 3 influenza seasons. Extended care was defined as new placement in a skilled nursing home/long-term/rehabilitation facility on hospital discharge. We focused on those treated with antiviral agents to explore the effect of early treatment on extended care and hospital length of stay using logistic regression and competing risk survival analysis, accounting for time from illness onset to hospitalization. Treatment was categorized as early (≤ 4 days) or late (>4 days) in reference to date of illness onset. RESULTS Among 6593 community-dwelling adults aged ≥ 65 years hospitalized for influenza, 18% required extended care at discharge. The need for care increased with age and neurologic disorders, intensive care unit admission, and pneumonia were predictors of care needs. Early treatment reduced the odds of extended care after hospital discharge for those hospitalized ≤ 2 or >2 days from illness onset (adjusted odds ratio, 0.38 [95% confidence interval {CI}, .17-.85] and 0.75 [.56-.97], respectively). Early treatment was also independently associated with reduction in length of stay for those hospitalized ≤ 2 days from illness onset (adjusted hazard ratio, 1.81; 95% CI, 1.43-2.30) or >2 days (1.30; 1.20-1.40). CONCLUSIONS Prompt antiviral treatment decreases the impact of influenza on older adults through shorten hospitalization and reduced extended care needs.

[1]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[2]  Alicia M Fry,et al.  Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. , 2014, The Lancet. Infectious diseases.

[3]  W. Schaffner,et al.  Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype. , 2013, The Journal of infectious diseases.

[4]  Robert Schechter,et al.  Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Hong Zhou,et al.  Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Hamers,et al.  Long-term consequences of an intensive care unit stay in older critically ill patients: design of a longitudinal study , 2011, BMC geriatrics.

[7]  J. Parienti,et al.  Predictors of mortality and short-term physical and cognitive dependence in critically ill persons 75 years and older: a prospective cohort study , 2011, Health and quality of life outcomes.

[8]  J. Rello,et al.  Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. , 2011, The Journal of antimicrobial chemotherapy.

[9]  Qingxia Chen,et al.  Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. , 2011, The Journal of infectious diseases.

[10]  L. Gubareva,et al.  Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[11]  Thomas M Gill,et al.  Change in disability after hospitalization or restricted activity in older persons. , 2010, JAMA.

[12]  J. Sung,et al.  Outcomes of adults hospitalised with severe influenza , 2010, Thorax.

[13]  Erin Burns,et al.  Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. , 2010, MMWR. Morbidity and mortality weekly report.

[14]  J. Sung,et al.  Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza , 2009, The Journal of infectious diseases.

[15]  A. Apisarnthanarak,et al.  Antiviral Treatment for Patients Hospitalized with Severe Influenza Infection May Affect Clinical Outcomes , 2008 .

[16]  J. Raboud,et al.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Sung,et al.  Factors Associated with Early Hospital Discharge of Adult Influenza Patients , 2007, Antiviral therapy.

[18]  Theodore R Holford,et al.  Hospitalization, restricted activity, and the development of disability among older persons. , 2004, JAMA.

[19]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[20]  C. Cox,et al.  A study of the impact of influenza on the functional status of frail older people. , 1998, Archives of internal medicine.

[21]  A. Falsey,et al.  Respiratory syncytial virus and influenza A infections in the hospitalized elderly. , 1995, The Journal of infectious diseases.